BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20198471)

  • 21. Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.
    Lipina T; Labrie V; Weiner I; Roder J
    Psychopharmacology (Berl); 2005 Apr; 179(1):54-67. PubMed ID: 15759151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
    Fone KCF; Watson DJG; Billiras RI; Sicard DI; Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Mol Neurobiol; 2020 May; 57(5):2144-2166. PubMed ID: 31960362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain.
    Long KD; Mastropaolo J; Rosse RB; Manaye KF; Deutsch SI
    Brain Res Bull; 2006 May; 69(6):626-30. PubMed ID: 16716829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
    Lane HY; Huang CL; Wu PL; Liu YC; Chang YC; Lin PY; Chen PW; Tsai G
    Biol Psychiatry; 2006 Sep; 60(6):645-9. PubMed ID: 16780811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.
    Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M
    Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of typical and atypical antipsychotics on human glycine transporters.
    Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
    Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
    Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
    Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
    Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
    Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
    Levin ED; Petro A; Caldwell DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain.
    McCoy L; Richfield EK
    Neurosci Lett; 1996 Aug; 213(2):137-41. PubMed ID: 8858627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action.
    Zhou X; Cai G; Mao S; Xu D; Xu X; Zhang R; Yao Z
    BMC Psychiatry; 2020 Mar; 20(1):106. PubMed ID: 32143671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.
    Hudson MR; Rind G; O'Brien TJ; Jones NC
    Transl Psychiatry; 2016 Apr; 6(4):e784. PubMed ID: 27093066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes.
    Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
    Br J Pharmacol; 2012 Mar; 165(5):1543-55. PubMed ID: 21880034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycine transporter-1: a new potential therapeutic target for schizophrenia.
    Hashimoto K
    Curr Pharm Des; 2011; 17(2):112-20. PubMed ID: 21355838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia.
    Rosenbrock H; Dorner-Ciossek C; Giovannini R; Schmid B; Schuelert N
    J Pharmacol Exp Ther; 2022 Aug; 382(2):223-232. PubMed ID: 35661632
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.
    Rezvani AH; Tizabi Y; Getachew B; Hauser SR; Caldwell DP; Hunter C; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1030-40. PubMed ID: 18343006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).
    Harsing LG; Zsilla G; Matyus P; Nagy KM; Marko B; Gyarmati Z; Timar J
    Acta Physiol Hung; 2012 Mar; 99(1):1-17. PubMed ID: 22425803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
    Yang SY; Hong CJ; Huang YH; Tsai SJ
    Neurosci Lett; 2010 Jan; 469(1):127-30. PubMed ID: 19944746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.